| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |